Cargando…
Microalbuminuria is a late event in patients with hypertension: Do we need a lower threshold?
BACKGROUND: Microalbuminuria (MA) is a marker of vascular damage. However, many studies have observed an increased risk at lower levels of albuminuria than are currently used to define MA. AIM: To verify early cardiovascular changes occurring before MA in hypertensive patients. MATERIALS AND METHODS...
Autores principales: | Wahab, Mohamed Abdel Kader Abdel, Saad, Mohamed Mohamed, Baraka, Khaled Abdel Ghany |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5247301/ https://www.ncbi.nlm.nih.gov/pubmed/28127216 http://dx.doi.org/10.1016/j.jsha.2015.12.003 |
Ejemplares similares
-
Association of PNPLA3 (rs738409) & TM6SF2 (rs58542926) and ATG16L1 (rs2241880) genetic variants with susceptibility to hepatocellular carcinoma in a group of Egyptian patients with HCV-induced liver cirrhosis
por: Mohamed Fteah, Asmaa, et al.
Publicado: (2023) -
Predictors of future microalbuminuria in children and adolescents with type 1 diabetes mellitus in Egypt
por: Habashy, Safinaz El, et al.
Publicado: (2019) -
Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?
por: Wahab, Mohamed Abdel Kader Abdel
Publicado: (2017) -
Radius of proximal isovelocity surface area in the assessment of rheumatic mitral stenosis: Connecting flow to anatomy and hemodynamics
por: Omar, Alaa Mabrouk Salem, et al.
Publicado: (2015) -
Coronavirus diseases 2019: Current biological situation and potential therapeutic perspective
por: Khan, Suliman, et al.
Publicado: (2020)